This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Effect of Multispecies Probiotic Supplementation on the Efficacy of Rifaximin α Therapy in Patients With Small Intestinal Bacterial Overgrowth (SIBO): a Randomized Placebo-controlled Trial | MicrobiomeTrials
← Back to trials NCT07426705
Effect of Multispecies Probiotic Supplementation on the Efficacy of Rifaximin α Therapy in Patients With Small Intestinal Bacterial Overgrowth (SIBO): a Randomized Placebo-controlled Trial Recruiting PHASE4 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-02-15Est. Completion: 2027-07-15
Enrollment target: 100 participantsOther microbiome trials you might be interested in Irritable Bowel Syndrome Irritable Bowel Syndrome With Diarrhea (IBS-D) Repetitive Transcranial Magnetic Stimulation (rTMS) Chronic Diarrhea Intestinal Flora
Objectives: This study aims to evaluate the clinical efficacy and safety of repetitive transcranial magnetic stimulation…
Suzhou, China Est. completion Jul 1, 2026
Small Intestinal Bacterial Overgrowth Syndrome (SIBO) Small Intestinal Bacterial Overgrowth
The goal of this trial is to evaluate the safety and tolerability of an 8-week, multi-component nutritional supplement (…
Portland, United States
Completed Feb 25, 2026
Bloating Rifaximin Functional Bowel Disorder Irritable Bowel Syndrome Constipation
This randomized, double-blind, placebo-controlled trial will evaluate whether a 14-day course of rifaximin improves bloa…
Bangkok Noi, Thailand Est. completion Oct 2027